/GNRS

GNRS Stock - The Greenrose Holding Company Inc.

Q: What is the analyst price target for GNRS?

Analyst price target information is not currently available for GNRS.

Q: What is GNRS's market cap?

Market capitalization information is not currently available for GNRS.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00-50.00%

$0.00 (-50.00%) • Apr 23

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for GNRS

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-170.34

52W High$0.28

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019
Revenue	$25.39M	$28.38M	N/A
Gross Profit	$15.00M	$26.78M	N/A
Gross Margin	59.1%	94.4%	N/A
Operating Income	$9.84M	$15.61M	$-6.597
Net Income	$17.93M	$714,625	$-6.597
Net Margin	70.6%	2.5%	N/A
EPS	$1.12	$3.46	$-0.00

Company Overview

Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.

Visit Website

Earnings History & Surprises

GNRS

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-2.18

Q3 2022

EPS Surprise History

Q3 20

No data

Q4 20

No data

Q1 21

No data

Q2 21

No data

Q3 21

No data

Q2 22

No data

Q3 22

No data

Q3 22

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2022	Sep 30, 2022	—	$-2.18	—	—
Q3 2022	Aug 26, 2022	—	$-0.63	—	—
Q2 2022	May 16, 2022	—	$-0.92	—	—
Q4 2021	Dec 31, 2021	—	—	—	—
Q3 2021	Sep 30, 2021	—	$-3.76	—	—
Q2 2021	Jun 30, 2021	—	$-0.06	—	—
Q1 2021	Mar 31, 2021	—	$-3.80	—	—
Q4 2020	Dec 31, 2020	—	$-0.03	—	—
Q3 2020	Sep 30, 2020	—	$-0.02	—	—
Q2 2020	Jun 30, 2020	—	$-0.04	—	—
Q1 2020	Mar 31, 2020	—	$0.14	—	—

Frequently Asked Questions about GNRS

What is GNRS's current stock price?

The Greenrose Holding Company Inc. (GNRS) is currently trading at $0.00 per share. The stock has moved -50.00% today.

What is the analyst price target for GNRS?

No analyst price targets are currently available for this stock.

What sector is The Greenrose Holding Company Inc. in?

The Greenrose Holding Company Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is GNRS's market cap?

The Greenrose Holding Company Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does GNRS pay dividends?

No, The Greenrose Holding Company Inc. does not currently pay a dividend to shareholders.